Evidence map›Paper›PMID 34618816›Full record

ArticlePloS one2021

Murine Type III interferons are functionally redundant and correlate with bacterial burden during influenza/bacterial super-infection.

Helen E Rich, Danielle Antos, Collin C McCourt, Wen Quan Zheng, Louis J Devito, Kevin J McHugh, Radha Gopal, Jieru Wang, John F Alcorn

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Roles and Effects of Interferon Lambda Signaling in the Context of Bacterial Infections.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2023
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Helen E RichDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States of America.
Danielle AntosDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States of America.ORCID 0000-0002-8451-0600
Collin C McCourtDepartment of Pediatrics, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, United States of America.
Wen Quan ZhengDepartment of Pediatrics, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, United States of America.
Louis J DevitoDepartment of Pediatrics, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, United States of America.
Kevin J McHughDepartment of Pediatrics, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, United States of America.
Radha GopalDepartment of Pediatrics, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, United States of America.
Jieru WangDepartment of Pediatrics, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, United States of America.
John F AlcornDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States of America.ORCID 0000-0001-5997-7711
Children's Hospital of Pittsburgh · USUniversity of Pittsburgh · US

Funding

Autoimmunity and Immunopathology Training ProgramT32AI089443 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SHLOMCHIK, MARK J · 2010 to 2024
$6.6M
Influenza A Inhibits TH17 Host Defense Against Bacterial PneumoniaR01HL107380 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ALCORN, JOHN F · 2012 to 2024
$5.4M
Immune mechanisms of influenza-induced exacerbation of atherosclerosisR01HL146479 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GOPAL, RADHA · 2020 to 2024
$1.9M
NHLBI NIH HHS R01 HL107380NHLBI NIH HHS R01 HL146479NIAID NIH HHS T32 AI089443
6 · The paper itself

Abstract

backgroundType III interferon, or interferon lambda (IFNλ) is a crucial antiviral cytokine induced by influenza infection. While IFNλ is important for anti-viral host defense, published data demonstrate that IFNλ is pathogenic during influenza/bacterial super-infection. It is known that polymorphisms in specific IFNλ genes affect influenza responses, but the effect of IFNλ subtypes on bacterial super-infection is unknown.

methodsUsing an established model of influenza, Staphylococcus aureus super-infection, we studied IFNλ3-/- and control mice to model a physiologically relevant reduction in IFNλ and to address its role in super-infection.

resultsSurprisingly, IFNλ3-/- mice did not have significantly lower total IFNλ than co-housed controls, and displayed no change in viral or bacterial clearance. Importantly, both control and IFNλ3-/- mice displayed a positive correlation between viral burden and total IFNλ in the bronchoalveolar lavage during influenza/bacterial super-infection, suggesting that higher influenza viral burden drives a similar total IFNλ response regardless of IFNλ3 gene integrity. Interestingly, total IFNλ levels positively correlated with bacterial burden, while viral burden and bronchoalveolar lavage cellularity did not.

conclusionsThese data suggest IFNλ2 can compensate for IFNλ3 to mount an effective antiviral and defense, revealing a functional redundancy in these highly similar IFNλ subtypes. Further, the IFNλ response to influenza, as opposed to changes in cellular inflammation or viral load, significantly correlates with susceptibility to bacterial super-infection. Moreover, the IFNλ response is regulated and involves redundant subtypes, suggesting it is of high importance to pulmonary pathogen defense.

Indexed as

AnimalsCell LineCoinfectionDogsFemaleInterferon LambdaInterferonsInterleukinsMadin Darby Canine Kidney CellsMaleMiceMice, Inbred C57BLMice, KnockoutOrthomyxoviridae InfectionsPolymorphism, GeneticStaphylococcal InfectionsIL28A protein, mouseInterferon Lambdainterferon-lambda protein, mouseInterferonsInterleukins

Identifiers

PMID34618816
PMCPMC8496871
OpenAlexW3202711653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.